Three directors resign from Tempest Therapeutics board effective May 22, 2026

Tempest Therapeutics, Inc.

Stephen Brady, Michael Raab, and Christine Pellizzari resigned from the Tempest board on May 22, 2026.
Resignations not due to any disagreement with the company on operations, policies, or practices.
Separation agreements waive accrued unpaid director retainer fees; stock options and indemnification remain.
Board size reduced by three members; no replacements announced.

item 5.02

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-237150
form_type: 8-K
ticker: TPST
cik: 0001544227
company_name: Tempest Therapeutics, Inc.
filed_at: 2026-05-22T21:05:53+00:00
discovered_at: 2026-05-22T21:08:00.250910+00:00
generated_at: 2026-05-22T21:09:46.337732+00:00
sec_items: ["5.02"]
event_type: leadership
sentiment: negative
materiality_score: 0.4
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-237150
json_url: https://secwatch.observer/filing/0001193125-26-237150.json
markdown_url: https://secwatch.observer/filing/0001193125-26-237150.md
text_url: https://secwatch.observer/filing/0001193125-26-237150.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312526237150/0001193125-26-237150-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312526237150/d29824d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Christine Pellizzari

Director

TPST · Tempest Therapeutics, Inc.

Effective: 2026-05-22
Filed: May 22, 2026 21:05 UTC

On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.

Departed

Michael Raab

Director

TPST · Tempest Therapeutics, Inc.

Effective: 2026-05-22
Filed: May 22, 2026 21:05 UTC

On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.

Departed

Stephen Brady

Director

TPST · Tempest Therapeutics, Inc.

Effective: 2026-05-22
Filed: May 22, 2026 21:05 UTC

On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.

Source-grounded claims

5310339e24

Christine Pellizzari resigned as Director at Tempest Therapeutics, Inc..

On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

6b76a16d94

Michael Raab resigned as Director at Tempest Therapeutics, Inc..

On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

7d5fc56857

Stephen Brady resigned as Director at Tempest Therapeutics, Inc..

On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Source: SEC EDGAR

accession 0001193125-26-237150

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.